Know Cancer

or
forgot password
  • cancer clinical trials in danbury, CT

  • Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Praxair Cancer Center at Danbury Hospital
    Danbury, Connecticut 06810
    Lung Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Praxair Cancer Center at Danbury Hospital
    Danbury, Connecticut 06810
    Esophageal Cancer, Gastric Cancer
    Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer
    Research Site
    Danbury, Connecticut
    Thyroid Cancer
    Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
    Praxair Cancer Center at Danbury Hospital
    Danbury, Connecticut 06810
    Colorectal Cancer
    Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.
    Danbury Hospital
    Danbury, Connecticut 06810
    Hepatitis C Virus, Advanced Fibrosis, Cirrhosis
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Danbury Hospital
    Danbury, Connecticut 06810
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Danbury Hospital
    Danbury, Connecticut 06810
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
    Research Site
    Danbury, Connecticut
    Bone Metastases in Subjects With Advanced Breast Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Danbury Hospital
    Danbury, Connecticut 06810
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    STEPP: A Phase 2, Open-label, Randomized Clinical Trial of Skin Toxicity Treatment in mCRC Subjects Receiving Panitumumab Concomitantly With Second-line Irinotecan Based Chemotherapy
    Research Site
    Danbury, Connecticut
    Metastatic Colorectal Cancer, Skin Rash, Skin Toxicities, Colon Cancer, Colorectal Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Praxair Cancer Center at Danbury Hospital
    Danbury, Connecticut 06810
    Breast Cancer
    First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
    Research Site
    Danbury, Connecticut
    Colorectal Cancer
    An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer
    Research Site
    Danbury, Connecticut
    Thyroid Cancer
    Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients
    Research Site
    Danbury, Connecticut
    Non Small Cell Lung Cancer, Lung Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Danbury Hospital
    Danbury, Connecticut 06810
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
    Research Site
    Danbury, Connecticut
    Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Danbury Hospital
    Danbury, Connecticut 06810
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Praxair Cancer Center at Danbury Hospital
    Danbury, Connecticut 06810
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    FTY720 in Patients With Primary Progressive Multiple Sclerosis
    Associated Neurologists, P.C.
    Danbury, Connecticut 06810
    Primary Progressive Multiple Sclerosis
    Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
    Research Site
    Danbury, Connecticut
    Recurrent Glioblastoma
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Praxair Cancer Center at Danbury Hospital
    Danbury, Connecticut 06810
    Endometrial Cancer, Fatigue, Neurotoxicity
    Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
    Research Site
    Danbury, Connecticut
    Non-Small Cell Lung Cancer, Anemia, Cancer, Lung Cancer
    Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
    Research Site
    Danbury, Connecticut
    Breast Cancer, Hypercalcemia of Malignancy, Colon Cancer, Endocrine Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Metastatic Cancer, Multiple Myeloma, Parathyroid Neoplasms, Renal Cancer, Thyroid Cancer, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Non-Small Cell Lung Cancer
    Collecting Tumor Samples From Patients With Gynecological Tumors
    Praxair Cancer Center at Danbury Hospital
    Danbury, Connecticut 06810
    Cancer
    PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
    Research Site
    Danbury, Connecticut
    Cancer, Colon Cancer, Colorectal Cancer, Fever, Locally Advanced, Metastatic Colorectal Cancer, Neutropenia, Rectal Cancer
    A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
    Research Site
    Danbury, Connecticut
    Cancer, Cataract, Low Bone Mineral Density, Osteopenia, Osteoporosis, Prostate Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Danbury Hospital
    Danbury, Connecticut 06810
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    Danbury Hospital Praxair Cancer Center
    Danbury, Connecticut
    Peripheral T-cell Lymphoma
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Danbury Hospital
    Danbury, Connecticut 06810
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Danbury Hospital
    Danbury, Connecticut 06810
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    TRINOVA-2: Trebananib in Ovarian Cancer-2
    Research Site
    Danbury, Connecticut
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Praxair Cancer Center at Danbury Hospital
    Danbury, Connecticut 06810
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
    Research Site
    Danbury, Connecticut
    Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
    TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
    Research Site
    Danbury, Connecticut
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer
    NOLAN: Naproxen or Loratadine and Neulasta
    Research Site
    Danbury, Connecticut
    Bone Pain in Stage I - III Breast Cancer
    A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors
    Research Site
    Danbury, Connecticut
    Advanced Malignancy, Advanced Solid Tumors, Cancer, Oncology, Oncology Patients, Tumors
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Praxair Cancer Center at Danbury Hospital
    Danbury, Connecticut 06810
    Melanoma (Skin)
    Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer
    Danbury Internal Medicine
    Danbury, Connecticut 06810
    Breast Cancer
    Iressa Expanded Access Program (EAP)
    Research Site
    Danbury, Connecticut
    Carcinoma, Non-small-cell Lung, Metastases, Neoplasm
    Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer
    Danbury Hospital/Praxair Cancer Center
    Danbury, Connecticut 06810
    Carcinoma, Non-Small-Cell Lung
    Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
    Research Site
    Danbury, Connecticut
    Non-Hodgkin's Lymphoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Praxair Cancer Center at Danbury Hospital
    Danbury, Connecticut 06810
    Pancreatic Cancer
    Iressa Versus Docetaxel (Taxotere)
    Research Site
    Danbury, Connecticut
    Non-Small-Cell Lung Carcinoma
    ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer
    Research Site
    Danbury, Connecticut
    Colorectal Cancer, Metastases
    Levocarnitine in Treating Fatigue in Cancer Patients
    Praxair Cancer Center at Danbury Hospital
    Danbury, Connecticut 06810
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
    Research Site
    Danbury, Connecticut
    Breast Neoplasms, Neoplasms, Hormone-Dependent
    Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
    Research Site
    Danbury, Connecticut
    Squamous Cell Carcinoma of the Head and Neck
    PROACT - Pre-Operative Arimidex Compared To Tamoxifen
    Research Site
    Danbury, Connecticut
    Breast Cancer
    GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin
    Research Site
    Danbury, Connecticut
    Type 2 Diabetes Mellitus
    Study of CP-675,206 in Refractory Melanoma
    Research Site
    Danbury, Connecticut
    Refractory Melanoma